Trial NCT02138838

View at ClinicalTrials.gov 
Org. Study IDs: 20130356
Secondary IDs: 2013-004958-18

Last trial update was posted on 2020-06-29

MeSH Interventions

Cinacalcet

MeSH Conditions

Hyperparathyroidism Hyperparathyroidism, Secondary Kidney Diseases Neoplasm Metastasis Renal Insufficiency, Chronic

Other Conditions

Chronic Kidney Disease, Secondary Hyperparathyroidism

Stopping Reasons

Amgen decided to terminate the study early to be able to meet US regulatory timelines fo filing. Subjects in treatment were rolled over to the 20140159 study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID